Kintara Therapeutics Investor Presentation — June 2022

Document content

Developing Advanced Oncology Therapies for Rare Unmet Medical Needs

Copyright © 2022 Kintara Therapeutics, Inc. CONFIDENTIAL

Corporate Presentation

June 2022Forward Looking Statements

2This presentation contains forward -looking statements based upon Kintara’s current expectations. This communication contains “forward -looking

statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward -looking statements are identifie d by terminology such as

“may,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “es timates,” “predicts,” “potential” or

“continue” or the negative of these terms or other similar words. These statements are only predictions. Kintara has based th eseforward -looking

statements largely on its then -current expectations and projections about future events, as well as the beliefs and assumptions of management. Forward -

looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that ar e beyond Kintara’s control,

and actual results could differ materially from those stated or implied in forward -looking statements due to a number of factors , including but not limited

to: (i) risks associated with the impact of the COVID -19 pandemic; (ii) risks and uncertainties relating to Kintara’s ability to develop, market and sell

products based on its technology; the expected benefits and efficacy of Kintara’s products and technology; the availability of substantial additional funding

for Kintara to continue its operations and to conduct research and development, clinical studies and future product commercia lization; and, Kintara’s

business, research, product development, regulatory approval, marketing and distribution plans and strategies, and (iii) thos e risks detailed in Kintara’s

most recent Annual Report on Form 10 -K and subsequent reports filed with the SEC, as well as other documents that may be filed b y Kintara from time to

time with the SEC. Accordingly, you should not rely upon forward -looking statements as predictions of future events. Kintara can not assure you that the

events and circumstances reflected in the forward -looking statements will be achieved or occur, and actual results could differ materially from those

projected in the forward -looking statements. The forward -looking statements made in this communication relate only to events as of the date on which

the statements are made. Except as required by applicable law or regulation, Kintara undertakes no obligation to update any f orward-looking statement to